In tumors such as non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma, and colorectal cancer, Trm cells preferentially expressed CD39, a surrogate marker of T cells recognizing tumor-specific antigens15,16. This evidence concerns the gene ENTPD1 and neoplasm.